Merit Medical To Acquire Brightwater Medical For $35M Upfront

Merit Medical Systems, Inc. MMSI will acquire Brightwater Medical for a $35 million upfront payment and potential earn-out payments of up to $15 million based on receipt of CE mark approval and achievement of future sales targets.

Merit Medical is a manufacturer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology and endoscopy.

Brightwater Medical’s primary product is the ConvertX, is a single device used to replace a series of devices and procedures used to treat severe obstructions of the ureter.

On Monday, Merit Medical shares were trading up 2.8% at $59.28.

Related Links:

The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs

IPO Outlook For The Week: Biotechs And A Grocery Outlet

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: M&ANews
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!